Oxyrane UK Limited

Overview

Legal name

OXYRANE UK LIMITED

Region

Unknown

Registered address

Unknown

Insolvency history

Corporate ownership

Updated 06 Jun 2026 16:52

Controls 1

Oxyrane UK Limited

No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

10 events

12 Nov

2024

Gazette Notice Voluntary

Gazette

GAZ1(A) | Transaction MzQ0MTg2NjY1OGFkaXF6a2N4 | Paper/PDF filed

Published 08 Nov 2024 12:40

04 Nov

2024

Dissolution Application Strike Off Company

Dissolution

DS01 | Transaction MzQ0MTgyMjY5N2FkaXF6a2N4

Published 04 Nov 2024 10:05

19 Aug

2024

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQzMjY1Njg0NmFkaXF6a2N4

Published 19 Aug 2024 18:58

19 Aug

2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzMjY1Njg3NWFkaXF6a2N4

Published 19 Aug 2024 18:54

19 Aug

2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzMjY1Njg0MGFkaXF6a2N4

Published 19 Aug 2024 18:53

19 Aug

2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzMjY1Njg0MmFkaXF6a2N4

Published 19 Aug 2024 18:53

19 Aug

2024

Change To A Person With Significant Control

Persons-with-significant-control

PSC04 | Transaction MzQzMjY1Njg0OWFkaXF6a2N4

Published 19 Aug 2024 18:53

19 Aug

2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzMjY1Njg0NGFkaXF6a2N4

Published 19 Aug 2024 18:53

19 Aug

2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzMjY1Njg0MWFkaXF6a2N4

Published 19 Aug 2024 18:53

12 Apr

2006

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2008

Funded years

2008

Age at first award

2 years

Projects

2008 Collaborative R&D Lead participant

Development of an integrated generic platform for the engineering, production and purification of monclonal antibodies

1 Jun 2008 to 30 Nov 2011

Awarded

£1,353,800

Total cost £3,149,256

Awaiting Public Summary

Product types

Collaborative R&D